NEW YORK (GenomeWeb News) — Navigenics, a Bay Area company focused on using whole-genome scanning to identify an individuals’ genetic risks for certain diseases, today said it has made its official debut as a company.
 
The firm said it has also secured a Series B round of venture capital financing for an undisclosed amount, bringing its total funding to $25 million to date.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.